ALMS — Alumis Inc

Ownership history in MPM BioImpact LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Alumis Inc (ALMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.68% (2025 Q4)
Avg. % of fund
2.68%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 2,401,992 — — 2.68% $23.4M $9.76
% of Fund (quarterly)    ALMS price (monthly, adj. close)

Other funds also holding ALMS

As of 2025 Q4 — sorted by position size

AyurMaya Capital Management Company, LP 100.0% Foresite Capital Management V, LLC 3Y 34.31% venBio Partners LLC 3Y 20.85% Yu Fan 3Y 8.35% Trium Capital LLP 3Y 6.76% Samsara BioCapital, LLC 3Y 7Y 5.8% Saturn V Capital Management LP 3Y 5.62% TOWERVIEW LLC 3Y 7Y 3.5% Octagon Capital Advisors LP 3Y 3.0% SR ONE CAPITAL MANAGEMENT, LP 3Y 2.71%
← Back to MPM BioImpact LLC Holdings